Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Thyroid Cancer
Clinical trial register · China

Thyroid Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Shanghai 13 Beijing 5 Fuzhou 4 Chengdu 3 Chongqing 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai13 Beijing5 Fuzhou4 Chengdu3 Chongqing2
All 21 locations
Target enrolment
to

Thyroid Cancer trials in China

31 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
39
Guangzhou
2026-09-20
Recruiting
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
NCT07707401Thyroid Diseases, Thyroid Cancer, Surgery, Postoperative Pain
Shanghai 6th People's Hospital
Not applicable
200
Shanghai
2026-09-09
Recruiting
Fudan University
Phase 2
72
Shanghai
2026-08-12
Recruiting
The First Affiliated Hospital of Xiamen University
Not applicable
120
Xiamen
2026-08-01
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous
FindCure Biosciences (ZhongShan) Co., Ltd.
Early Phase 1
10
Wuxi
2026-04-20
Recruiting
SHAOYAN LIU
Phase 1
12
Beijing
2026-01-01
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Not applicable
150
Tianjin
2026-01-01
Recruiting
Fujian Medical University
Observational
120
Fuzhou
2025-12-23
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
520
Hangzhou
2025-12-19
Active, closed
Second Affiliated Hospital of Nanchang University
Observational
2,000
Nanchang
2025-10-01
Not yet open
West China Hospital
Not applicable
600
Chengdu
2025-05-01
Recruiting
Fudan University
Phase 2
60
Shanghai
2025-04-21
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
144
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Gui'lin, Liuzhou
2025-04-18
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2025-02-01
Recruiting
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
NCT06730321Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Thyroid Cancer, Papillary
Shanghai 6th People's Hospital
Observational
200
Shanghai
2024-12-12
Not yet open
West China Hospital
Phase 2
20
Chengdu
2024-12-01
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Recruiting
Fudan University
Phase 3
250
Shanghai
2024-11-19
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
Yu Wang
Phase 2
14
Shanghai
2024-07-24
Recruiting
Fudan University
Observational
48
Shanghai
2024-07-18
Recruiting
Fudan University
Phase 3
124
Shanghai
2024-07-11
Recruiting
Fudan University
Observational
80
Shanghai
2024-07-02
Recruiting
Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy
NCT06738888Thyroid Cancer, Thyroid Diseases, Thyroid Nodule
Shanghai 6th People's Hospital
Observational
300
Shanghai
2024-05-01
Recruiting
Fujian Medical University
Observational
100
Fuzhou
2024-03-01
Active, closed
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
National Health Research Institutes, Taiwan
Observational
300
2022-08-29
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
140
Beijing
2022-08-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
1,199
Beijing
2022-07-01
Recruiting
Shandong Provincial Hospital
Observational
1,600
Jinan
2012-01-01
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china/condition/thyroid-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies listing the condition Thyroid Cancer.

How many Thyroid Cancer trials are recruiting in China?

25 of the 31 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Thyroid Cancer), 31 studies
PhaseStudiesRecruitingShare
Observational121038.7%
Phase 26519.4%
Not applicable5316.1%
Phase 34412.9%
Phase 1216.5%
Early Phase 1113.2%
Phase 1/2113.2%

Most active sponsors

Lead sponsors with the most studies (Thyroid Cancer)
Lead sponsorStudiesRecruiting
Fudan University66
Shanghai 6th People's Hospital33
Cancer Institute and Hospital, Chinese Academy of Medical Sciences22
Fujian Medical University22
Ruijin Hospital22
West China Hospital20
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11
FindCure Biosciences (ZhongShan) Co., Ltd.11
Nanjing First Hospital, Nanjing Medical University11
National Health Research Institutes, Taiwan10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.